Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Metastatic Non-Small Cell Lung Cancer (NSCLC). Show all posts
Showing posts with label Metastatic Non-Small Cell Lung Cancer (NSCLC). Show all posts
Thursday, January 19, 2023

FDA Approves Krazati (adagrasib) for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation

›
Mirati Therapeutics, Inc.   (NASDAQ: MRTX), a targeted oncology company, announced the U.S. Food and Drug Administration (FDA)  approval of ...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.